{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-24-000021","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2024-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.982025+00:00","generated_at":"2026-06-05T00:34:07.190714+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BeiGene files patent suits against Sandoz and MSN to block generic BRUKINSA until 2034","bullets":["Filed Hatch-Waxman infringement suits in District of New Jersey after Sandoz and MSN filed ANDAs with Paragraph IV certifications.","Composition of matter patent for BRUKINSA not challenged; remains intact and expires in 2034.","Complaints seek permanent injunction to prevent generic commercialization before expiration of asserted Orange Book patents.","ANDA litigation common in pharma; additional notices from other generic companies may follow."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-24-000021","json":"https://secwatch.observer/filing/0001651308-24-000021.json","markdown":"https://secwatch.observer/filing/0001651308-24-000021.md","text":"https://secwatch.observer/filing/0001651308-24-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000021/0001651308-24-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000021/bgne-20240308.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:34:07.190714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}